(Reuters) -MeiraGTx Holdings has signed a deal with Eli Lilly, potentially worth over $475 million, granting the pharma giant ...

November is Diabetic Eye Disease Awareness Month. Experts share tips on prevention, early symptoms, and why yearly dilated ...

Effective management of inherited retinal diseases requires a comprehensive approach to diagnosis and treatment, according to ...

Targeting Tear Function for Sustained Relief” convenes leading experts in ophthalmology and optometry to discuss evolving ...

The Korea Research Institute of Standards and Science (KRISS) has developed a retina-mimicking eye phantom that faithfully ...

Go to or scan the QR code and use code LIST to get your free FM Topper when you order your Journey Pack today. WATCH OUR ...

MeiraGTx is cashing in on a gene therapy that restored vision to 11 children who were born legally blind, licensing the ...

Targeting Tear Function for Sustained Relief” convenes leading experts in ophthalmology and optometry to discuss evolving ...

MeiraGTx Holdings is licensing a genetic eye disease medicine to Eli Lilly in a deal worth up to $475 million.

Dr Sunir Garg explores how AI is transforming retinal care, from individualized treatments to tracking disease progression ...

AI-driven oculomics is transforming eye scans into powerful tools for detecting heart, brain, and metabolic health risks ...

Physicians highlight early intervention, safety, and access limitations as key unmet needs-Tepezza SC anticipated to reshape ...